HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
HYTN Innovations Inc.'s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.
National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (CSE:EMH).
Subsequently, Emerald announced a change in business strategy that would result in the winding down of all cannabis related activities, including its partnership with HYTN.
HYTN's receipt of the license amendment ensures that it can continue to sell its all-natural, sugar and calorie-free sparkling cannabis beverages across Canada.
"Achieving this milestone under a strict timeline was a monumental feat lead by our exceptional operations team," Jason Broome, HYTN's chief operations officer, said. "This amendment coupled with the strong demand we have already seen will allow HYTN to execute on its sales objectives."
"Emerald's decision to pivot out of cannabis accelerated our plan and timeline to achieve the license amendment," HYTN CEO, Elliot McKerr, commented. "We are now well positioned to recapture the 13.5% margin contribution previously associated with our agreement with Emerald."
The company noted that plans are now in place to ensure a smooth transition for all existing customers.
Photo: Courtesy of Tim Foster on Unsplash
HYTN Innovations Inc.'s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.
HYTN創新公司的(CSE：HYTN)子公司HYTN大麻公司vt.，有加拿大衞生部批准了一項許可證修正案，允許向省和地區授權的零售商銷售大麻提取物、食用大麻和大麻局部產品。
National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (CSE:EMH).
通過與Emerald Health Treeutics Inc.的合作協議，HYTN注入大麻的起泡飲料已經開始在全國銷售。(TSXV：EMH)(OTCQX：EMHTF)(CSE：EMH)。
Subsequently, Emerald announced a change in business strategy that would result in the winding down of all cannabis related activities, including its partnership with HYTN.
後來，Emerald宣佈改變商業戰略，將導致所有與大麻相關的活動逐步結束，包括與HYTN的合作伙伴關係。
HYTN's receipt of the license amendment ensures that it can continue to sell its all-natural, sugar and calorie-free sparkling cannabis beverages across Canada.
HYTN收到許可證修正案，確保其可以繼續在加拿大各地銷售其全天然、無糖和無卡路里的起泡大麻飲料。
"Achieving this milestone under a strict timeline was a monumental feat lead by our exceptional operations team," Jason Broome, HYTN's chief operations officer, said. "This amendment coupled with the strong demand we have already seen will allow HYTN to execute on its sales objectives."
在嚴格的時間表下實現這一里程碑是我們卓越的運營團隊領導的一項不朽的壯舉。“HYTN首席運營官傑森·布魯姆(Jason Broome)説。“這項修訂，加上我們已經看到的強勁需求，將使和記黃埔能夠實現其銷售目標。”
"Emerald's decision to pivot out of cannabis accelerated our plan and timeline to achieve the license amendment," HYTN CEO, Elliot McKerr, commented. "We are now well positioned to recapture the 13.5% margin contribution previously associated with our agreement with Emerald."
“Emerald戒除大麻的決定加快了我們實現許可證修正案的計劃和時間表。”HYTN首席執行官埃利奧特·麥克爾，評論説。我們現在處於有利地位，可以重新獲得之前與Emerald達成的協議所帶來的13.5%的利潤率。“
The company noted that plans are now in place to ensure a smooth transition for all existing customers.
該公司指出，現在已經制定了計劃，以確保所有現有客户的平穩過渡。
Photo: Courtesy of Tim Foster on Unsplash
圖片來源：Unspash上的蒂姆·福斯特(Tim Foster)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧